bioRxiv Science⌕ Search

Biology subjects

Symonds, E. K. C.

Publications and source records attributed to Symonds, E. K. C..

2 recordsLinked to original sources

Development of a 3D in vitro wound healing model to assess the effect of ADSC-EVs on vascularisation

Angiogenesis is critical for effective wound healing and relies on the successful coordination of various cell types including endothelial cells, macrophages, and fibroblasts. Adipose-derived stem cell extracellular vesicles (ADSC-EVs) have demonstrated pro-angiogenic properties and have been posited as a novel therapeutic to aid wound healing; however, their functional impact within human-derived multicellular models remains largely uncharacterised. This study explores the development and application of a 3D multicellular in vitro model to assess the effects of ADSC-EVs on vascularisation in the context of wound healing. 3D multicellular in vitro models were developed by co-culturing human umbilical vein endothelial cells (HUVECs), monocyte-derived macrophages (MDMs), and fibroblasts within Matrigel to recapitulate the in vivo wound healing microenvironment. A five-colour confocal microscopy panel was developed to visualise each cell type and EVs within the models. The optimised models were then treated ADSC-EVs or control to determine their impact on angiogenesis and cell co-localisation. We determined that vessel formation was significantly enhanced when HUVECs were co-cultured in multicellular models compared to monocultures, with the greatest effect observed in the full three-cell-type model. This effect was even more pronounced with the addition of ADSC-EVs. ADSC-EV treatment also enhanced macrophage co-localisation within endothelial structures. This study developed a multicellular model that can be used for future work assessing wound healing in vitro and will be additive to currently used single-cell and in vivo models. We have applied these models to demonstrate that ADSC-EVs significantly enhance tube formation in HUVECs, and the development of tissue-like structures in multicell systems, highlighting their potential as a promising therapeutic approach for improving wound healing.

cell biology↗

ADSC-EVs modulate primary human macrophages to an anti-inflammatory phenotype in vitro

BackgroundEVs released by adipose derived stem cells (ADSCs) have shown promise as a therapeutic for tissue repair and regeneration because of their purported immune-regulatory properties. In this capacity, ADSC-EVs could be beneficial in improving graft retention rates for autologous fat grafting (AFG) post-mastectomy as, currently, grafted tissue rates are reported to be variable and low. Enriching grafted tissue with ADSC-EVs may improve retention rates by modulating macrophages resident within both the breast and lipoaspirate. We aimed to identify key macrophage phenotypes that are modulated by ADSC-EVs in vitro. MethodsADSCs were isolated from lipoaspirates of women undergoing AFG and characterised by flow cytometry and differentiation potential. ADSC-EVs were isolated from cell culture media and characterised by tunable resistive pulse sensing (TRPS), transmission electron microscopy (TEM), and Western blot. Primary monocyte-derived macrophages were polarized to an M1-like (GM-CSF, IFN{gamma}) or M2-like phenotype (M-CSF, IL-4) or maintained (M0-like; M-CSF) and, at the time of polarization, ADSC-EVs were co-cultured with macrophages for 48 hrs. Flow cytometry coupled with high-dimensional analysis was used to cluster macrophages post co-culture. A manual gating strategy was generated to recapitulate these clusters and was applied to a repeat experimental run. Both runs were analysed to examine the prevalence of each cluster, representing a unique macrophage phenotype, with and without ADSC-EVs. ResultsFollowing the addition of ADSC-EVs, M0-like macrophages demonstrated a reciprocal shift of cell distribution from a cluster defined as having a high inflammatory profile (CD36+++CD206+++CD86+++; 38.6{+/-}14.8% of M1-like macrophages without ADSC-EVs; 16.5{+/-}7.0% with ADSC-EVs; p<0.0001) to a cluster with a lower inflammatory profile (CD36+CD206+CD86+; 16.6{+/-}11.2% to 35{+/-}21.5%; p<0.05). There was no shift in M2-like clusters following treatment with ADSC-EVs. ConclusionsADSC-EVs are complex regulators of macrophage phenotype that can shift macrophages away from a heightened pro-inflammatory state.

molecular biology↗